MedTrace Logo

The Cardiovascular Effects of Ginger (Zingiber Officinale) in Patients With Type II Diabetes Mellitus

NCT04222738 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-01-10

No results posted yet for this study

Summary

The aim of the study was the evaluation of cardiovascular benefits of Zingiber officinale Roscoe in patients with type 2 diabetes mellitus before and after 6 weeks of add-on therapy.

Conditions

  • Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy

Interventions

DIETARY_SUPPLEMENT

GINOFF1

The intervention lasted for six weeks and consisted of the administration of powdered ginger extracts in the form of capsules at a dose of 2g/day.

Sponsors & Collaborators

  • NGATI Denetria NYONGA, Dr

    collaborator UNKNOWN

  • SOBNGWI Eugène, Pr

    collaborator UNKNOWN

  • MBANYA Jean Claude, Pr

    collaborator UNKNOWN

  • Yaounde Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Chris Nadege NGANOU-GNINDJIO, MD, MAS · Yaounde Central Hospital

  • Eugene SOBNGWI, Professor · Yaounde Central Hospital

  • Jean Claude MBANYA, Professor · Yaounde Central Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Cameroon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04222738 on ClinicalTrials.gov